POINT Biopharma Global

YTD

ALL

Why Robinhood?

You can watch PNT and buy or sell other stocks, ETFs, and their options commission-free!

About PNT

POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), manufacturing technology and novel direct-to-patient targeting to revolutionize theragnostic drug development and radioligand commercialization.

CEO

Joe McCann, PhD

CEOJoe McCann, PhD

Employees

—

Employees—

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

2020

Founded2020

Employees

—

Employees—

PNT Key Statistics

Market cap

1.33B

Market cap1.33B

Price-Earnings ratio

13.97

Price-Earnings ratio13.97

Dividend yield

—

Dividend yield—

Average volume

411.37K

Average volume411.37K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$14.35

52 Week high$14.35

52 Week low

$6.57

52 Week low$6.57